| Reagan-Udall Foundation

Read more about AstraZeneca Pharmaceuticals LP

Read more about Astellas Pharma US

Read more about Arrowhead Pharmaceuticals, Inc.

Read more about ArmaGen

Read more about Amryt Pharmaceuticals

Read more about Amicus Therapeutics

Expanded Access Listings

Expanded Access for ATB200/AT2221 for the Treatment of IOPD

Conditions

Pompe Disease Infantile-Onset

This is an expanded access program (EAP) for eligible participants designed to provideaccess to ATB200/AT2221.

Read more about Amgen

Read more about Alnylam Pharmaceuticals

Read more about AlloVir, Inc.

Read more about Alkermes